LacriJet® is FCI latest and exclusive preloaded & self-retaining monocanalicular nasolacrimal intubation indicated for epiphora, congenital nasolacrimal duct obstruction and canalicular laceration. LacriJet® consists of a single use injector handpiece into which a silicone tube is preloaded inside a metallic guide. Its special design enables to reduce operating time, either in the intubation phase as well as for the removal of the device.
Learn more at:
🌐 www.fciworldwide.com/products...
🇺🇸 fci-ophthalmics.com/products/...
Follow us on LinkedIn:
🖥️ / fci-. .